Clinical Trials Browser

Phase 2/3 × Unknown × folfirinox × Clear all

NCT05181605 2022-08-09

Survival Analysis After Neoadjuvant Therapy in Patients With Resectable Pancreatic Cancer and Risk Factors

Phase 2/3 Unknown

Gastrointestinal

Pancreatic Adenocarcinoma

NCT02311439 2014-12-08

Induction Chemotherapy, FOLFIRINOX Followed With Concurrent Capecitabine and Radiation Therapy in Inoperable Locally Advanced Cancer of the Pancreas

Phase 2/3 Unknown

Gastrointestinal

Pancreatic Neoplasms